Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The retinoic acid receptor (RAR) is a nuclear receptor that functions as a ligand-activated transcription factor. It is activated by retinoic acid and regulates gene expression in development, cell growth, differentiation, and various physiological processes. RARs heterodimerize with RXRs and bind to RAREs to control transcription. They are important drug targets in cancer and metabolic diseases.
Ligand binding induces conformational changes, leading to dissociation of corepressors and recruitment of coactivators, enabling transcriptional activation of target genes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic Acid Receptor (RAR).